NCT04847271

Brief Summary

Background: physical inactivity is a main cause of childhood obesity. Physical activity on prescription (PAP) is an evidence-based intervention for adults, but has not been evaluated in children with obesity. Aim: to evaluate the feasibility of a PAP intervention for children with obesity by assessing both clinical patient outcomes and implementation outcomes. Method: a single-arm clinical trial in which children with obesity participate in a 4-month PAP intervention. Measurement points are baseline and 4 months, with long-term follow-ups at 8 and 12 months. Population: children with obesity. Intervention: physical activity on prescription (PAP). Patient outcomes: physical activity level/pattern (including sedentary time), BMI, waist circumference, metabolic risk markers, health-related quality of life, self-efficacy for physical activity, motivation for physical activity. Implementation outcomes: coherence, cognitive participation, collective action, and reflexive monitoring in relation to PAP (the four core constructs of the Normalization Process Theory); appropriateness, acceptability and feasibility of PAP; barriers and facilitators for implementing PAP; recruitment and attrition rates, and intervention fidelity and adherence.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
10 months until next milestone

Study Start

First participant enrolled

February 7, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

3.3 years

First QC Date

March 29, 2021

Last Update Submit

July 9, 2024

Conditions

Keywords

obesity, childhoodphysical activity

Outcome Measures

Primary Outcomes (1)

  • Change in physical activity level

    Change in time spent in moderate to vigorous physical activity, measured with accelerometry

    4, 8, 12 months after baseline

Secondary Outcomes (12)

  • Change in physical activity pattern

    4, 8, 12 months after baseline

  • Change in BMI

    4, 8, 12 months after baseline

  • Change in health-related quality of life

    4, 8, 12 months after baseline

  • Change in self-efficacy for physical activity

    4, 8, 12 months after baseline

  • Change in motivation for physical activity

    4, 8, 12 months after baseline

  • +7 more secondary outcomes

Other Outcomes (4)

  • Change in healthcare practitioners' attitudes towards PAP in relation to the four core constructs of the NPT: coherence, cognitive participation, collective action, and reflexive monitoring

    Pre-implementation to post-intervention at 4 months, and long-term follow-up at 12 months

  • Change in healthcare practitioners' acceptability of the PAP intervention

    Pre-implementation to post-intervention at 4 months, and long-term follow-up at 12 months

  • Change in healthcare practitioners' appropriateness of the PAP intervention

    Pre-implementation to post-intervention at 4 months, and long-term follow-up at 12 months

  • +1 more other outcomes

Study Arms (1)

Physical activity on prescription

EXPERIMENTAL

Physical activity on prescription is a behaviour change intervention comprising 3 components: a person-centred pre-intervention dialogue, a written prescription for individually tailored physical activity, and a structured follow-up.

Behavioral: Physical activity on prescription (PAP)

Interventions

The intervention in this study will comprise the 3 PAP components. Participants will take part in all components and perform one or several physical activities of their choice in accordance to the written prescription, at the prescribed frequency and duration, for a period of 4 months.

Physical activity on prescription

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \- being a healthcare practitioner or manager involved in the treatment of children with obesity at a paediatric healthcare clinic in Region Västra Götaland
  • Clinical trial/patients:
  • aged 6-12 years
  • diagnosed with obesity (age adjusted BMI\>ISO-BMI 30)
  • having an insufficient physical activity level according to national recommendations
  • being willing to participate and perform the chosen activity/-ies
  • having a parent who is willing to participate.

You may not qualify if:

  • severe psychiatric comorbidity
  • severe intellectual or physical disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regionhälsan, Region Västra Götaland

Gothenburg, Sweden

Location

Related Publications (1)

  • Bernhardsson S, Boman C, Lundqvist S, Arvidsson D, Borjesson M, Larsson MEH, Lundh H, Melin K, Nilsen P, Lauruschkus K. Implementation of physical activity on prescription for children with obesity in paediatric health care (IMPA): protocol for a feasibility and evaluation study using quantitative and qualitative methods. Pilot Feasibility Stud. 2022 Jun 1;8(1):117. doi: 10.1186/s40814-022-01075-3.

MeSH Terms

Conditions

Pediatric ObesityMotor Activity

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Susanne Bernhardsson, Assoc. Prof.

    Vastra Gotaland Region

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, Research and Development Strategist, R&D primary health care

Study Record Dates

First Submitted

March 29, 2021

First Posted

April 19, 2021

Study Start

February 7, 2022

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

July 10, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

IPD will be shared upon reasonable request

Time Frame
After completion of the study and publication of study results

Locations